Decheng Capital China Life Sciences USD Fund III L.P. 13D/13G Filings for Alpine Immune Sciences, Inc. (ALPN)

Decheng Capital China Life Sciences USD Fund III L.P. 13D and 13G filings for Alpine Immune Sciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-05-21
4:49 pm
Sale		2024-05-1813DAlpine Immune Sciences, Inc.
ALPN		Decheng Capital China Life Sciences USD Fund III L.P.0
0.000%		-8,368,166decrease
(Position Closed)		Filing
2024-04-30
4:20 pm
Purchase		2024-04-1013DAlpine Immune Sciences, Inc.
ALPN		Decheng Capital China Life Sciences USD Fund III L.P.8,368,166
12.800%		7,292increase
(+0.09%)		Filing
2023-11-14
4:16 pm
Purchase		2023-11-0913DAlpine Immune Sciences, Inc.
ALPN		Decheng Capital China Life Sciences USD Fund III L.P.8,360,874
14.100%		386,667increase
(+4.85%)		Filing
2022-09-27
4:00 pm
Purchase		2022-09-2313DAlpine Immune Sciences, Inc.
ALPN		Decheng Capital China Life Sciences USD Fund III L.P.7,974,207
17.600%		2,010,246increase
(+33.71%)		Filing
2021-09-21
5:04 pm
Purchase		2021-09-1713DAlpine Immune Sciences, Inc.
ALPN		Decheng Capital China Life Sciences USD Fund III L.P.5,963,961
19.600%		1,554,240increase
(+35.25%)		Filing
2020-07-31
7:49 pm
Purchase		2020-07-2813DAlpine Immune Sciences, Inc.
ALPN		Decheng Capital China Life Sciences USD Fund III L.P.4,409,721
17.700%		563,132increase
(+14.64%)		Filing